February 25, 2014

DSN recently caught up with Dick Domann, VP pharmacy services for TrialCard, to talk about adherence and abandonment solutions. Capturing otherwise lost scripts is a significant opportunity for retail pharmacy, and TrialCard has a tool to help reclaim those prescriptions.

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

August 27, 2013

How can retail pharmacy play a greater role in battling the nation's prescription drug abuse epidemic? Data. To shed light on how CVS Caremark tapped its extensive prescribing database to identify signs of potential inappropriate prescribing, CVS Caremark¹s Troy Brennan talked with DSN about the program and the ongoing efforts to combat prescription drug abuse.

August 20, 2013

A pair of pharmacists from Whitsett, N.C., were the winners of a special text-to-vote competition to highlight independent pharmacy best practices at the Cardinal Health 2013 Retail Business Conference.

August 5, 2013

Rob Hooper, national sales manager for OTC with Actavis Pharmaceutical, sat down with DSN to discuss how Actavis is preparing for the inaugural NACDS Total Store Expo. Actavis Pharmaceutical, one of the leaders in the OTC private label industry and recently acquired by Watson Pharmaceutical, plans to leverage its extensive experience within the prescription medicine business to offer best-in-class options across store brand products.

July 10, 2013

DSN had the opportunity to speak with Christian Tadrus, who has been the pharmacist at Sam’s Health Mart in the Colombia, Mo. area, since 1997. Tadrus, a member of McKesson’s Sponsored Clinical Services pharmacy network, participates in a number of adherence support programs, including the award-winning Pharmacy Intervention adherence coaching program, StudyLink patient recruitment for clinical trials program, and the RxRapid Response pharmacist survey program.

May 6, 2013

There is no substitute for the face-to-face counsel of the pharmacist in improving patient adherence — and he’s got the data to prove it. That’s the message Thrifty White president and CEO Bob Narveson had for DSNTV in part two of a frank and broad-ranging interview about the state of the industry, the role community pharmacy can play in healthcare reform and the results of an exciting new study that validates the role companies like his can play to innovate patient care, improve outcomes and lower healthcare costs.

April 12, 2013

Westport VP and general manager Paul Hemings spoke with DSN about the company's introduction of Zephrex-D, a meth-resistant pseudoephedrine product, to market. Beyond taking a bite out of the $23.5 billion methamphetamine trade, Hemings discussed the benefits of having Zephrex-D behind the pharmacy counter.

April 2, 2013

DSN caught up with Greg Bradley — president and CEO of Advantage Consumer Healthcare, a full turnkey solution center for over-the-counter medicines reaching the market — for an overview of the new marketing and sales solution company as it has recently brought to market OraSure Technologies' OraQuick Advance, a take-home HIV test kit that the Food and Drug Administration recently approved for the self-care market, and Westport Pharmaceuticals' Zephrex-D, a pseudoephedrine product with a unique point of differentiation.

July 11, 2012

DSN talked to Cardinal Health SVP independent sales Steve Lawrence about the big news from Cardinal’s 2012 Retail Business Conference, including a best practices competition for its customers, its Women in Pharmacy program and Cardinal’s joint outreach program with the Ohio State University College of Pharmacy aimed at preventing prescription drug abuse.

September 11, 2014

Par Pharmaceutical Cos. earlier this week resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, the generic form of Hospira's Precedex injection. 

September 10, 2014

The Food and Drug Administration recently announced the availability of the “Purple Book,” which lists biological products in much the same way that the "Orange Book" lists pharmaceuticals. 

September 10, 2014

Kmart has announced that its Kmart Pharmacy, located at 901 US 27 North, Sebring, Fla., was the subject of a data incident on or around May 27, 2012.
 


September 9, 2014

Attorney General Eric Holder announced a new Drug Enforcement Administration regulation that would allow pharmacies and other authorized collectors to serve as authorized drop-off sites for unused prescription drugs.

September 9, 2014

Giant Food of Landover on Tuesday introduced Rx Timer Cap, an electronic cap that is an alternative to the traditional prescription medication caps. 

September 9, 2014

The Food and Drug Administration is on pace to match or exceed the 39 novel new medicines approved in 2012.

September 8, 2014

Camber Consumer Care, which focuses on both consumer care and prescription-to-OTC switch products, introduced new executives to its staff. 

September 8, 2014

Mylan is now free to resume distribution of its generic Precedex product (dexmedetomidine hydrochloride injection) to customers, effective immediately. 

September 8, 2014

Silvergate Pharmaceuticals on Monday announced that the Food and Drug Administration approved Epaned (enalapril maleate Powder for oral solution) for the treatment of symptomatic heart failure, as well as the treatment of asymptomatic left ventricular dysfunction. 

September 8, 2014

QS/1, a healthcare automation solutions provider, on Monday announced that it now offers Veridikal Intelligence and Veridikal’s Reconciliation program to the pharmacies it serves. The program includes pre/post editing, EDI support, 835 processing, forensic auditing and reconciliation. 

September 4, 2014

The Drug Enforcement Administration National Prescription Drug Take-Back Day collection site locator is now available online, the National Association of Boards of Pharmacy reported Wednesday.

September 4, 2014

Kline Group reported positive signs of 2013 growth across the over-the-counter sector in its recently published Nonprescription Drugs USA study, according to a blog posted Monday

September 4, 2014

Rite Aid on Thursday reported a 3.2% lift in sales for the 26 weeks ended Aug. 30, ringing in $12.9 billion. 

 

September 4, 2014

Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug.